Seattle Genetics



Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.


Add photos to showcase Seattle Genetics’s culture


Add Seattle Genetics’s values

Insider experiences

Share your experience of working at Seattle Genetics

Clay B. Siegall
Chairman, President & CEO
Charles Romp
Executive Vice President, Commercial
Christopher Pawlowicz
Executive VP, Human Resources
Jean I. Liu
General Counsel, Executive VP, Legal Affairs
Nancy Whiting
Executive VP, Late Stage Development
Natasha Hernday
EVP, Corporate Development
Rachel Lenington
SVP, Program and Portfolio Management
Roger D. Dansey
Chief Medical Officer
Sankyo Park Davis
Senior Vice President, Sales
Todd E. Simpson
Chief Financial Officer
Tuomo Pätsi
Executive Vice President, Commercial International
Vaughn B. Himes
Chief Technical Officer

Add your teams to show how people work together at Seattle Genetics

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.